title: Role of endogenous vasopressin in development of gastric ulcer induced by restraint and water immersion.
abstract: To elucidate the role of arginine vasopressin (AVP) in the development of stress-induced gastric ulcer, the mucosal lesions after restraint and water immersion were examined in Brattleboro strain rats with hereditary hypothalamic diabetes insipidus (DI) and in Long-Evans rats (LE) used as controls. Restrained animals were immersed in water for 2 h, and the size of lesion was expressed as percentage of the lesion area to the total glandular mucosal area, which were defined as ulcer index (UI). In DI rats, UI was significantly higher than in control LE rats, despite the attenuated responses of plasma adrenocorticotropic hormone (ACTH) to stress. Although subcutaneous injection of selective antidiuretic analogue 1-desamino-8-D-AVP did not affect UI, intracerebroventricular (icv) administration of AVP reduced UI in DI rats, and icv administration of V1 antagonist [d(CH2)5Tyr(Me)]AVP elevated UI in LE rats. These results indicate that endogenous AVP plays a role in preventing the formation of gastric ulcers induced by stress via a central V1 receptor. Furthermore, we suggest that elevation of ACTH in plasma is not essential in the development of stress-induced gastric ulcer in rats.
authors.affiliation: Department of Medicine, Jichi Medical School, Tochigi, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Honda
authors.forename: S
authors.initials: S
authors.lastname: Fukuda
authors.forename: S E
authors.initials: SE
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Kuzuya
authors.forename: T
authors.initials: T
authors.lastname: Saito
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000378:metabolism*; D000818:Animals; D001127:Arginine Vasopressin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000502:physiology*; D002552:Cerebral Ventricles / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000494:pharmacology*; D003919:Diabetes Insipidus / Q000235:genetics / Q000503:physiopathology; D004837:Epinephrine / Q000097:blood; D005753:Gastric Mucosa / Q000473:pathology* / Q000503:physiopathology; D007101:Immersion; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D008297:Male; D009638:Norepinephrine / Q000097:blood; D051381:Rats; D011910:Rats, Brattleboro; D012149:Restraint, Physical; D013045:Species Specificity; D013276:Stomach Ulcer / Q000503:physiopathology* / Q000523:psychology; D013315:Stress, Psychological / Q000503:physiopathology*
chemical_list: D001127:Arginine Vasopressin; C025043:vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-; D000324:Adrenocorticotropic Hormone; D003894:Deamino Arginine Vasopressin; D009638:Norepinephrine; D004837:Epinephrine